Ubiquinol (Reduced CoQ10) is a longevity product whose active basis is electron-transport cofactor. Supports heart energy and blood-vessel function. It is positioned for resale to the growing healthspan-focused consumer market.
Improves endothelial function in heart-failure patients. Research relevant to this mechanism is indexed on PubMed and linked below; it describes the mechanism rather than this specific product.
Peer-reviewed studies on the active compound — citations link to PubMed.
“Ubiquinol led to significant improvement in peripheral endothelial function”
“significant increase in total CoQ10 levels in the ubiquinol group compared to placebo”
“CoQ10 appears to have beneficial effects in reducing duration and frequency of migraine attack.”
“However, CoQ10 was more effective than placebo in reducing migraine days/month (P < 0.00001) and migraine duration (P = 0.009).”
“CoQ10 was superior to placebo for attack-frequency, headache-days and days-with-nausea in the third treatment month and well tolerated; 50%-responder-rate for attack frequency was 14.4% for placebo and 47.6% for CoQ10 (number-needed-to-treat: 3).”
Research describes the active mechanism and is not a claim about this specific product.
Slightly reduces coronary mortality and events. Research relevant to this mechanism is…
Counters sarcopenia, frailty and bone loss in aging. Research relevant to this mechanism…
Counters oxidative stress accumulating with age. Research relevant to this mechanism is…
Maintains immune competence across the lifespan. Research relevant to this mechanism is…
Yes — its active compound is linked to 5 peer-reviewed studies, summarized and cited above.
You can buy it on Amazon via the link above; Magellan earns a small affiliate commission at no extra cost to you, which does not affect the evidence grade.
Dietary supplements and devices are generally well tolerated but are not a substitute for medical care. Talk to your physician before starting, especially if you take medication or have a health condition.